FDA Device Approvals

presented by
Devices & Diagnostics

Texas medical device company scores FDA nod for hammertoe fixation system

San Antonio, Texas-based BioMedical Enterprises received FDA clearance for its HammerLock Nitinol Intramedullary Fixation System upgrade. The system’s original innovation? No wires. The upgrade has a linear body that allows more bone fusion at the joint, which according to a company statement, offers “enhanced flexibility in positioning and easier reduction.” The implant is made of Nitinol, a […]

Devices & Diagnostics

FDA to 23andMe: Stop selling spit kits

Star startup 23andMe got slammed with an FDA warning letter Nov. 22. The letter says the healthcare startup’s genetic testing spit kits are being marketed without clearance or approval. It goes so far as to say the diagnostics applications, including “carrier status,” is a medical device usage, and therefore requires premarket approval or de novo […]

Devices & Diagnostics

BSX scores FDA device approval for drug-eluting stent for coronary artery disease patients

Boston Scientific (BSX) received FDA device approval for its Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System, a next-gen polymer drug-eluting stent. The product launches immediately in the U.S. It will be used to treat patients with coronary artery disease. The company boasts the system offers “unparalleled visibility, low recoil, exceptional radial strength and fracture resistance, […]